Starring Chris Evans, Emily Blunt, Andy Garcia, Catherine O’Hara, Brian d’Arcy James, Chloe Coleman, Jay Duplass, and more in the leading roles, Pain Hustlers is all set to release on the streaming giant this October. Directed by veteran filmmaker David Yates, Pain Hustlers is a true story based on the infamous US-based pharma company Insys Therapeutics whose main product was Subsys, a sublingual liquid form of the drug fentanyl.
While Emily Blunt's character of Lizza is fiction, Pain Hustlers is a real story based on the crime drama novel The Hard Sell: Crime and Punishment at an Opioid Startup by writer Evan Hughes. Courtesy of the starcast and even the filmmaker, Pain Hustlers is among the much-awaited movie of the year released on streaming platforms. Now, the question arises what is Pain Hustlers OTT release date or Pain Hustlers Streaming date or where to stream Pain Hustlers? To know the answer continue reading-
Pain Hustlers OTT Details
Talking about where to stream Pain Hustlers, the Chris Evans-Emily Blunt starrer movie will be available to watch on Netflix from October 27, 2023. However, the movie is slated to be released in selected theaters first in the US on October 20, 2023. Talking about who is playing what in Netflix's movie Pain Hustlers, Emily Blunt plays the character of Liza Drake, Chris Evans plays Pete Brenner, Andy Garcia as Dr. Jack Neel, Catherine O’Hara as Jackie Drake, and more. The synopsis of Pain Hustlers movie says, "Dreaming of a better life for her and her young daughter, Liza (Emily Blunt) lands a job from Pete (Chris Evans) at a failing pharma start-up, where Liza’s charm, drive, and guts catapult her into the high life and the company into the center of a criminal conspiracy with dire consequences."
Pain Hustlers True Story
Pain Hustlers is a real story based on the infamous American pharmaceutical company Insys Therapeutics whose main product was Subsys, a sublingual liquid form of the drug fentanyl. Not only this, the Arizona-based company had employed nefarious racketeering tactics with prescription drugs. It is pertinent to mention here that in 2019 Insys Therapeutics filed for bankruptcy 10 days after it agreed to pay a whopping $225 million to settle separate criminal and civil cases brought by the U.S. Justice Department.
The pharma company was founded in 1990 by American multi-millionaire John Kapoor. John served as CEO and president after former CEO Michael Babich was arrested. Kapoor retired from Insys in 2017 due to racketeering conspiracy charges and was ultimately replaced by Saeed Motahari. Insys' main product was Subsys, a sublingual liquid form of the drug fentanyl. Fentanyl is an extremely fast-acting and powerful opioid used to relieve peaks of pain in cancer patients. Notably, fentanyl is also used in illicit drugs, especially cocaine and it indeed is dangerous for lives.